The downgrade to Neutral suggests a more cautious view on Evercore's stock, indicating that UBS does not see significant upside potential in the near term. However, the increase in the price target to $176 implies that UBS still sees some positive aspects to EVR's valuation, albeit less compelling than before. The mixed signals could lead to a neutral short-term impact on the stock price as the market digests both the downgrade and the higher price target.